X
Xu Xiao
Researcher at Xiamen University
Publications - 13
Citations - 57
Xu Xiao is an academic researcher from Xiamen University. The author has contributed to research in topics: Biology & Medicine. The author has an hindex of 2, co-authored 7 publications receiving 11 citations.
Papers
More filters
Journal ArticleDOI
Comparison of high-throughput single-cell RNA sequencing data processing pipelines.
TL;DR: This work encapsulated seven existing high-throughput scRNA-seq data processing pipelines with Nextflow, a general integrative workflow management framework, and evaluated their performance in terms of running time, computational resource consumption and data analysis consistency using eight public datasets generated from five different high-Throughput sc RNA-seq platforms.
Posted ContentDOI
DAISM-DNN: Highly accurate cell type proportion estimation with in silico data augmentation and deep neural networks
TL;DR: The evaluation results demonstrate that the DAISM-DNN pipeline outperforms other existing methods consistently and substantially for all the cell types under evaluation on real-world datasets.
Journal ArticleDOI
Dice-XMBD: Deep Learning-Based Cell Segmentation for Imaging Mass Cytometry.
TL;DR: Dice-XMBD as discussed by the authors combines nuclear proteins and membrane/cytoplasm proteins as two channels of input to generate more accurate single cell masks efficiently on IMC images produced with different nuclear, membrane and cytoplastic markers.
Journal ArticleDOI
Opioid-induced fragile-like regulatory T cells contribute to withdrawal
Yongsheng Zhu,Peng Yan,Rui Wang,Jianghua Liu,Hua Tang,Xu Xiao,Rongshan Yu,Xiaorui Bao,F. Zhu,Kena Wang,Ye Lu,Jie Dang,Chao Zhu,Rui-san Zhang,Weibo Dang,Bao Chun Zhang,Quanze Fu,Qian Zhang,Chongao Kang,Yujie Chen,Xiaoyu Chen,Qing Liang,Kejia Wang +22 more
TL;DR: In this paper , the landscape of peripheral immune cells from patients with opioid use disorder and from healthy controls was characterized, and it was shown that opioids increase the expression of neuron-derived C-C motif chemokine ligand 2 (Ccl2) and disrupted blood-brain barrier (BBB) integrity through the downregulation of astrocyte-derived fatty acid binding protein 7 (Fabp7), which both triggered peripheral Treg infiltration into nucleus accumbens (NAc) neurons, modulating subsequent withdrawal symptoms.